Notable Analyst Rating Changes 8/4: CX, NEU, CHK, AKAM Upgraded; DE, AKS, ESRX, ELN Downgraded
More News related to AKAM
- The Wizetrade Group Leverages Akamai Technologies and Microsoft Silverlight to launch the Next Generation of Wizetrade TV ... in HD
- Akamai Technologies (AKAM) Cutting 110 Employees
- Akamai to Take Cost Cutting Measures to Support Continued Investment in Key Areas
- Akamai Releases Third Quarterly "State of the Internet" Report
- Akamai Helps Customers Decrease Time-to-Value for Application Acceleration with Configuration Manager
More News related to AKS
- AK Steel (AKS) Plans Salaried Workforce Pay Cut, Other Cost Reduction Measures
- AK Steel Plans Salaried Workforce Pay Cut, Other Cost Reduction Measures
- AK Steel Announces January 2009 Surcharges for Electrical and Stainless Steels
- Quarterly Data Confirms Hedge Funds Exited Stocks In A Big Way
- AK Steel Presents Awards to Top Suppliers and Processors
More News related to AMGN
- Citi Maintains 'Buy' Rating on Amgen (AMGN), Adds Stock to Top Picks Live List
- Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
- Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
- Quarterly Data Confirms Hedge Funds Exited Stocks In A Big Way
- (OTC: MNIA) MNI Nutraceuticals, Inc. Receives Purchase Order for Vital Slim
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Morgan Stanley upgrades Cemex (NYSE: CX) from Underweight to Equal Weight, citing valuation.
Oppenheimer and Gabelli upgrade NewMarket (NYSE: NEU) to Outperform and Buy, respectively.
Capital One Southcoast upgrades Chesapeake Energy Corp. (NYSE: CHK) from Add to Strong Buy with a $92 price target, citing an attractive valuation and upcoming catalysts.
Jefferies upgrades Akamai (Nasdaq: AKAM) from Hold to Buy with a $29 price target.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Goldman Sachs downgrades Deere & Co. (NYSE: DE) from Buy to Neutral.
Longbow Reseach downgrades AK Steel (NYSE: AKS) from Buy to Neutral.
Broadpoint Capital downgrades Express Scripts (Nasdaq: ESRX) from Strong Buy to Buy.
Credit Suisse downgrades Elan (NYSE: ELN) from Outperform to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Banc of America initiates coveage on Amgen (Nasdaq: AMGN) with a Buy rating and $70 price target.
Morgan Joseph initiates coverage on Immunogenic (NASDAQ: IMGN) with a Buy rating and a $7 price target.
Merriman Curhan Ford initiates coverage on Cree (Nasdaq: CREE) with a Neutral rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.43
+0.15Related Entities
- Credit Suisse
- Goldman Sachs
- Morgan Stanley
- Jefferies & Co
- Banc of America
- Morgan Joseph
- Merriman Curhan Ford
- Broadpoint Capital
- Capital One Southcoast
- Longbow Research
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
